Puma Biotechnology Inc

Most Recent

  • uploads///thermometer headache pain pills
    Company & Industry Overviews

    ASCO 2019 Presentations: Late-Stage Breast Cancer Trials

    The annual ASCO (American Society of Clinical Oncology) 2019 meeting will be held on May 31–June 4 in Chicago.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Puma Biotechnology Reduced Guidance for NERLYNX Sales

    During its first-quarter earnings conference call, Puma Biotechnology (PBYI) reduced its guidance for fiscal 2019 net sales of NERLYNX in the US market.

    By Margaret Patrick
  • uploads///medic _
    Company & Industry Overviews

    Why Clovis Oncology Stock Rose 48% in November

    On December 3, Clovis Oncology stock closed at $19.08, which represents ~10.87% growth from its close of $17.21 on November 30.

    By Daniel Collins
  • uploads///dna _
    Earnings Report

    Portola Pharmaceuticals Stock Rose after Its Q3 2018 Results

    On November 8, after Portola Pharmaceuticals released its third-quarter financial results, the stock price rose 21.41%.

    By Daniel Collins
  • uploads///Perjeta
    Company & Industry Overviews

    Perjeta Could Significantly Boost Roche’s Revenue Growth in 2018

    In December 2017, the Food and Drug Administration approved Roche’s (RHHBY) Perjeta based on the results of its phase three Aphinity trial.

    By Daniel Collins
  • uploads///Spectrum Pharmaceuticals Revenue Trend
    Company & Industry Overviews

    Chart in Focus: Spectrum Pharmaceuticals’ Financials

    In 3Q17, Spectrum Pharmaceuticals (SPPI) raised $114.0 million from the sale of 12.6 million shares through its security offering program.

    By Kenneth Smith
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.